QIX Deutschland
|
16 161,24
|
53,70
|
0,33 %
|
Analysen zu QIX Deutschland-Werten
| 11.01.24 | RATIONAL Underperform | RBC Capital Markets | |
| 11.01.24 | Deutsche Börse Buy | Deutsche Bank AG | |
| 10.01.24 | Merck Buy | Jefferies & Company Inc. | |
| 10.01.24 | adidas Market-Perform | Bernstein Research | |
| 10.01.24 | Symrise Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Henkel vz. Neutral | JP Morgan Chase & Co. | |
| 10.01.24 | Fresenius Medical Care Neutral | UBS AG | |
| 10.01.24 | Siemens Healthineers Buy | UBS AG | |
| 10.01.24 | Carl Zeiss Meditec Buy | UBS AG | |
| 10.01.24 | SAP Buy | UBS AG | |
| 10.01.24 | Henkel vz. Underperform | Bernstein Research | |
| 10.01.24 | freenet Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 10.01.24 | Siemens Healthineers Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Symrise Market-Perform | Bernstein Research | |
| 10.01.24 | Evonik Outperform | Bernstein Research | |
| 09.01.24 | Evonik Hold | Jefferies & Company Inc. | |
| 09.01.24 | Merck Buy | Jefferies & Company Inc. | |
| 09.01.24 | Deutsche Börse Neutral | Goldman Sachs Group Inc. | |
| 09.01.24 | Carl Zeiss Meditec Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 09.01.24 | adidas Overweight | JP Morgan Chase & Co. | |
| 09.01.24 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
| 09.01.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Hannover Rück Outperform | RBC Capital Markets | |
| 08.01.24 | Fresenius Medical Care Market-Perform | Bernstein Research | |
| 08.01.24 | Bechtle Buy | Warburg Research | |
| 08.01.24 | adidas Sector Perform | RBC Capital Markets | |
| 08.01.24 | Covestro Buy | Jefferies & Company Inc. | |
| 08.01.24 | Siemens Healthineers Overweight | Morgan Stanley | |
| 08.01.24 | Fresenius Medical Care Underweight | Morgan Stanley | |
| 08.01.24 | Carl Zeiss Meditec Buy | UBS AG | |
| 05.01.24 | adidas Sell | Hauck & Aufhäuser Privatbankiers KGaA | |
| 05.01.24 | Deutsche Börse Buy | UBS AG | |
| 04.01.24 | Nemetschek Equal Weight | Barclays Capital | |
| 04.01.24 | SAP Overweight | Barclays Capital | |
| 04.01.24 | Siemens Healthineers Overweight | Barclays Capital | |
| 04.01.24 | RATIONAL Overweight | Barclays Capital | |
| 04.01.24 | Hannover Rück Outperform | RBC Capital Markets | |
| 04.01.24 | Sartorius vz. Hold | Deutsche Bank AG | |
| 03.01.24 | Knorr-Bremse Underweight | Barclays Capital | |
| 03.01.24 | Symrise Buy | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.